-+ 0.00%
-+ 0.00%
-+ 0.00%

Elanco Animal Health Raises FY2025 Adj EPS Guidance from $0.85-$0.91 to $0.91-$0.94 vs $0.90 Est; Raises FY2025 Sales Guidance from $4.570B-$4.620B to $4.645B-$4.670B vs $4.603B Est

Benzinga·11/05/2025 11:30:49
Listen to the news

Financial Guidance

Elanco is updating financial guidance for the full year 2025, summarized in the following table.

2025 Full Year

(dollars in millions, except per share amounts)



 

August

Guidance



 

November

Guidance



 


 


 


 


 


 


 


 


 
Revenue

 
$4,570 to $4,620

 
$4,645 to $4,670
Reported Net Loss

 
$(38) to $(14)

 
$(56) to $(41)
Adjusted EBITDA

 
$850 to $890

 
$880 to $900
Reported Loss per Share

 
$(0.08) to $(0.03)

 
$(0.11) to $(0.08)
Adjusted Earnings per Share

 
$0.85 to $0.91

 
$0.91 to $0.94